Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
暂无分享，去创建一个
A. Jakubowiak | S. Trudel | A. Lesokhin | N. Raje | M. Sebag | M. Solh | C. Basu | C. Costello | N. Bahlis | Y. Jethava | M. Savona | J. Chou | C. Gasparetto | M. Levy | Michael P. Chu | C. Udata | H. Krupka | A. Dalovisio